Neuroendocrine Tumors: Targeted Therapies

home / insights / neuroendocrine-tumors-targeted-therapies

An overview of neuroendocrine tumors and comprehensive insight on the novel targeted therapies that are improving outcomes for patients.

Understanding the Diagnosis and Prognosis of Neuroendocrine Tumors

EP. 1: Understanding the Diagnosis and Prognosis of Neuroendocrine Tumors

Diane Reidy-Lagunes, MD, Memorial Sloan-Kettering Cancer Center
August 20th 2021
Neuroendocrine Tumor Pathogenesis and Molecular Testing

EP. 2: Neuroendocrine Tumor Pathogenesis and Molecular Testing

Diane Reidy-Lagunes, MD, Memorial Sloan-Kettering Cancer Center
August 20th 2021
An Overview of Treatment Approaches for Neuroendocrine Tumors

EP. 3: An Overview of Treatment Approaches for Neuroendocrine Tumors

Diane Reidy-Lagunes, MD, Memorial Sloan-Kettering Cancer Center
August 27th 2021
Neuroendocrine Tumors: Factors That Inform Therapy Selection

EP. 4: Neuroendocrine Tumors: Factors That Inform Therapy Selection

Diane Reidy-Lagunes, MD, Memorial Sloan-Kettering Cancer Center
August 27th 2021
Systemic Therapy for Advanced Neuroendocrine Tumors

EP. 5: Systemic Therapy for Advanced Neuroendocrine Tumors

Diane Reidy-Lagunes, MD, Memorial Sloan-Kettering Cancer Center
September 3rd 2021
Advanced Neuroendocrine Tumors: VEGF-Targeted Therapies

EP. 6: Advanced Neuroendocrine Tumors: VEGF-Targeted Therapies

Diane Reidy-Lagunes, MD, Memorial Sloan-Kettering Cancer Center
September 3rd 2021
Advanced Neuroendocrine Tumors: Clinical Trials With Surufatinib

EP. 7: Advanced Neuroendocrine Tumors: Clinical Trials With Surufatinib

Diane Reidy-Lagunes, MD, Memorial Sloan-Kettering Cancer Center
September 10th 2021
Future Directions in the Management of Neuroendocrine Tumors

EP. 8: Future Directions in the Management of Neuroendocrine Tumors

Diane Reidy-Lagunes, MD, Memorial Sloan-Kettering Cancer Center
September 10th 2021
The Nature of Neuroendocrine Tumors

EP. 9: The Nature of Neuroendocrine Tumors

Matthew H. Kulke, MD, Dana-Farber Cancer Institute
September 17th 2021
Neuroendocrine Tumors: Options for Initial Therapy

EP. 10: Neuroendocrine Tumors: Options for Initial Therapy

Matthew H. Kulke, MD, Dana-Farber Cancer Institute
September 17th 2021